U.S. prices for the world's 20 top-selling medicines are, on average, three times higher than in Britain, according to an analysis carried out for Reuters.
The finding underscores a transatlantic gulf between the price of treatments for a range of diseases and follows demands for lower drug costs in America from industry critics such as Democratic presidential candidate Hillary Clinton.
The 20 medicines, which together accounted for 15 percent of global pharmaceuticals spending in 2014, are a major source of profits for companies including AbbVie (ABBV.N), AstraZeneca (AZN.L), Merck (MRK.N), Pfizer (PFE.N) and Roche (ROG.VX).
(Score: 2) by frojack on Thursday October 15 2015, @11:43PM
This is not news, this is how the world pays for drug research, it outsourced it all to the Americans.
Further, it is how the world pays for drug treatment in the second and third world. US Drugs in US Packaging, shipped from the US, at some tiny fraction of the price your drug store chain can order it in bulk.
Its not JUST that the US pays for research (some of that goes on in the EU as well), we pay for the day to day health care in indigent nations.
Further, we as a society are not all together against that situation, and we even send grant money to countries to buy drugs from us at cut rate prices, or we ship medicine directly. All done with tax dollars, which most Americans don't begrudge.
And because so much of the drugs used in the US are paid for by insurance (of one kind or another) we don't even see these price differences until we travel overseas and even then all we see is the non-prescription stuff.
No, you are mistaken. I've always had this sig.